title: Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
authors.affiliation: Department of Clinical Immunology, Huddinge Hospital, Sweden.
authors.forename: O
authors.initials: O
authors.lastname: Ringdén
authors.forename: M
authors.initials: M
authors.lastname: Remberger
authors.forename: J
authors.initials: J
authors.lastname: Mattsson
authors.forename: J
authors.initials: J
authors.lastname: Aschan
authors.forename: H
authors.initials: H
authors.lastname: Hägglund
authors.forename: S
authors.initials: S
authors.lastname: Carlens
authors.forename: B
authors.initials: B
authors.lastname: Lönnqvist
authors.forename: E
authors.initials: E
authors.lastname: Sparrelid
authors.forename: P
authors.initials: P
authors.lastname: Ljungman
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D006086:Graft vs Host Disease / Q000453:epidemiology; D006650:Histocompatibility Testing; D006801:Humans; D015994:Incidence; D007223:Infant; D007938:Leukemia / Q000097:blood / Q000628:therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D007958:Leukocyte Count; D008875:Middle Aged; D009504:Neutrophils; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D011336:Probability; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate